Search This Blog

Translate

Blog Archive

Middleboro Review 2

NEW CONTENT MOVED TO MIDDLEBORO REVIEW 2

Toyota

Since the Dilly, Dally, Delay & Stall Law Firms are adding their billable hours, the Toyota U.S.A. and Route 44 Toyota posts have been separated here:

Route 44 Toyota Sold Me A Lemon



Showing posts with label Eli Lilly. Show all posts
Showing posts with label Eli Lilly. Show all posts

Friday, November 4, 2016

CorpWatch: Eli Lilly Raised U.S. Prices Of Diabetes Drug 700 Percent Over 20 Years




Eli Lilly Raised U.S. Prices Of Diabetes Drug 700 Percent Over 20 Years
by Pratap Chatterjee, CorpWatch Blog
November 2nd, 2016

Photo: rachellynnae©. Used under Creative Commons license.
Eli Lilly, an Indianapolis based company, that has sold insulin products to diabetes patients since 1921, has quietly raised some U.S. prices 700 percent in the last 20 years by marketing so-called improved versions to consumers. Novo Nordisk, a Danish company, has also profited handsomely from this practice.

Insulin is a $23 billion global business with over 75 percent of the revenue coming from such new and improved versions.

A recent Washington Post analysis of the price increases has stirred up outrage. The newspaper noted that Humalog, an Eli Lilly brand of insulin that was sold for $21 per bottle in the U.S. 20 years ago, is now priced at $255, which represents a 700 percent markup, after adjusting for inflation.

"People are dying or getting sicker because they can’t afford their insulin, just so Eli Lilly and Novo Nordisk can make outrageous profits," Bernie Sanders, a U.S. senator and former presidential candidate, tweeted.

"The history of insulin captures one of the mystifying complexities of the pharmaceutical market — how long-standing drugs become more expensive with time and competition fails to hold down prices," writes Carolyn Y. Johnson in the Washington Post. "Companies point to improvements in their drugs, but medical experts say some of those changes are simply a strategy to keep prices high with new patent protections."

"I don’t think it takes a cynic such as myself to see most of these drugs are being developed to preserve patent protection," David Nathan, a Harvard Medical School professor, told the newspaper. "The truth is they are marginally different, and the clinical benefits of them over the older drugs have been zero."

In reality, part of the problem is also the private insurance system that controls most U.S. healthcare, under which new drug prices are set via deals struck between insurance and pharmaceutical companies. Most patients do not pay the full cost of a drug up front but absorb the cost eventually via an increase in their monthly healthcare premiums.

This is because U.S. residents pay for healthcare via such monthly plans with private insurance companies, unlike other developed countries where the government provides or regulates healthcare costs.

As a result pharmaceutical companies have the ability to charge as much as the U.S. insurance companies will let them. And since both parties profit from higher prices, the net effect is that prices continue to rise.

Not surprisingly, the costs of insulin overseas is not quite as high because government led healthcare systems typically negotiate much lower rates because they need to control costs. Thus a prescription of Lantus, manufactured by Sanofi-Aventis, another major insulin manufacturer, costs $70 in France but $450 in the U.S.  However, most drugs cannot be legally imported from other countries, so U.S. consumers cannot take advantage of lower prices elsewhere.

Sanders has pointed out the irony of this system. "If we can import tomatoes from Mexico, there is absolutely no reason why we cannot import affordable prescription drugs from Canada," he tweeted back in February.

Eli Lilly says that they are only one player in a complex system where prices are set. "A permanent solution that gives everyone who uses insulin reasonable access will require leadership and cooperation across many stakeholders, including manufacturers, PBMs, payers, and policymakers," an Eli Lilly spokesperson told the media.

Sanders tweet about Eli Lilly had an impact - investors began to dump the company shares, causing the stock price to drop some three percent.

Meanwhile, the rising cost of insulin is also a major concern for patients in developing countries. This past April, the World Health Organization issued its first global report on the diabetes epidemic in which it noted that a month of insulin treatment costs government workers the equivalent of 20 days pay in Malawi and seven in Nepal.

Indeed David Beran, a researcher at the University of Geneva’s division of tropical and humanitarian medicine, says that some 50 million people around the world have major problems paying for diabetes treatment.




Wednesday, February 13, 2013

A Choice For Corporate America: Are You With America Or The Cayman Islands

We need more Senators like Senator Bernie Sanders willing to speak the Truth about Corporate Greed and Failed Republican Tax Policy that allows such abuse!

Thank you, Vermont!


A Choice For Corporate America: Are You With America Or The Cayman Islands
By Senator Bernie Sanders


February 9, 2013


When the greed, recklessness, and illegal behavior on Wall Street drove this country into the deepest recession since the 1930s, the largest financial institutions in the United States took every advantage of being American. They just loved their country - and the willingness of the American people to provide them with the largest bailout in world history. In 2008, Congress approved a $700 billion gift to Wall Street. Another $16 trillion in virtually zero interest loans and other financial assistance came from the Federal Reserve. America. What a great country.

But just two years later, as soon as these giant financial institutions started making record-breaking profits again, they suddenly lost their love for their native country. At a time when the nation was suffering from a huge deficit, largely created by the recession that Wall Street caused, the major financial institutions did everything they could to avoid paying American taxes by establishing shell corporations in the Cayman Islands and other tax havens.

In 2010, Bank of America set up more than 200 subsidiaries in the Cayman Islands (which has a corporate tax rate of 0.0 percent) to avoid paying U.S. taxes. It worked. Not only did Bank of America pay nothing in federal income taxes, but it received a rebate from the IRS worth $1.9 billion that year. They are not alone. In 2010, JP Morgan Chase operated 83 subsidiaries incorporated in offshore tax havens to avoid paying some $4.9 billion in U.S. taxes. That same year Goldman Sachs operated 39 subsidiaries in offshore tax havens to avoid an estimated $3.3 billion in U.S. taxes. Citigroup has paid no federal income taxes for the last four years after receiving a total of $2.5 trillion in financial assistance from the Federal Reserve during the financial crisis.

On and on it goes. Wall Street banks and large companies love America when they need corporate welfare. But when it comes to paying American taxes or American wages, they want nothing to do with this country. That has got to change.

Offshore tax abuse is not just limited to Wall Street. Each and every year corporations and the wealthy are avoiding more than $100 billion in U.S. taxes by sheltering their income offshore.

Pharmaceutical companies like Eli Lilly and Pfizer have fought to make it illegal for the American people to buy cheaper prescription drugs from Canada and Europe. But, during tax season, Eli Lilly and Pfizer shift drug patents and profits to the Netherlands and other offshore tax havens to avoid paying U.S. taxes.

Apple wants all of the advantages of being an American company, but it doesn't want to pay American taxes or American wages. It creates the iPad, the iPhone, the iPod, and iTunes in the United States, but manufactures most of its products in China so it doesn't have to pay American wages. Then it shifts most of its profits to Ireland, Luxembourg, the British Virgin Islands and other tax havens to avoid paying U.S. taxes. Without such maneuvers, Apple's federal tax bill in the United States would have been $2.4 billion higher in 2011.

Offshore tax schemes have become so absurd that one five-story office building in the Cayman Islands is now the "home" to more than 18,000 corporations.

This tax avoidance does not just reduce the revenue that we need to pay for education, healthcare, roads, and environmental protection, it is also costing us millions of American jobs. Today, companies are using these same tax schemes to lower their tax bills by shipping American jobs and factories abroad. These tax breaks have contributed to the loss of more than 5 million U.S. manufacturing jobs and the closure of more than 56,000 factories since 2000. That also has got to change.

At a time when we have a $16.5 trillion national debt; at a time when roughly one-quarter of the largest corporations in America are paying no federal income taxes; and at a time when corporate profits are at an all-time high; it is past time for Wall Street and corporate America to pay their fair share.

That's what the Corporate Tax Dodging Prevention Act (S.250) that I have introduced with Rep. Jan Schakowsky (D-Ill.) is all about.

This legislation will stop profitable Wall Street banks and corporations from sheltering profits in the Cayman Islands and other tax havens to avoid paying U.S. taxes. It will also stop rewarding companies that ship jobs and factories overseas with tax breaks. The Joint Committee on Taxation has estimated in the past that the provisions in this bill will raise more than $590 billion in revenue over the next decade.

As Congress debates deficit reduction, it is clear that we must raise significant new revenue. At 15.8 percent of GDP, federal revenue is at almost the lowest point in 60 years. Our Republican colleagues want to balance the budget on the backs of the elderly, the sick, the children, the veterans and the most vulnerable by making massive cuts. At a time when the middle class already is disappearing, that is not only a grossly immoral position, it is bad economics.

We have a much better idea. Wall Street and the largest corporations in the country must begin to pay their fair share of taxes. They must not be able to continue hiding their profits offshore and shipping American jobs overseas to avoid taxes.

Here's the simple truth. You can't be an American company only when you want a massive bailout from the American people. You have also got to be an American company, and pay your fair share of taxes, as we struggle with the deficit and adequate funding for the needs of the American people. If Wall Street and corporate America don't agree, the next time they need a bailout let them go to the Cayman Islands, let them go to Bermuda, let them go to the Bahamas and let them ask those countries for corporate welfare.

http://www.huffingtonpost.com/rep-bernie-sanders/a-choice-for-corporate-am_b_2652176.html